Results presented today at the American College of Rheumatology in Boston show that a 12-biomarker test did a better job of predicting radiographic progression in patients with RA. The study ...

Doctors may order a cyclic citrullinated peptide (CCP) antibody test and other exams to confirm or rule out a rheumatoid arthritis (RA) diagnosis. A positive CCP antibody test doesn’t necessarily mean ...

Lake Charles, LA (KPLC) - Rheumatoid arthritis is a progressive autoimmune disease that if left untreated, can attack the joints and internal organs. There are medications that can help block the ...

Rheumatoid arthritis is a painful, progressive joint disease characterized by particularly acute flare-ups. Biologics, used to treat autoimmune diseases such as rheumatoid arthritis, target symptom ...

Is there a possibility of having some type of rheumatoid arthritis (RA), even though it doesn’t show up clearly in the blood work? (My CRP level was 0.3, rheumatoid factor was 10, anti-CCP result was ...

Precision medicine company Aqtual has secured $31m in a Series B financing round to progress its active chromatin cell-free DNA (cfDNA) platform and launch a rheumatoid arthritis (RA) therapy response ...

Unlike typical osteoarthritis, where cartilage in joints breaks down, rheumatoid arthritis results from the immune system attacking healthy tissues.

Seven years ago, Northeastern graduate Susan Dina Ghiassian was the first employee of Scipher Medicine Corp., a precision medicine company co-founded by Northeastern professor Albert-László Barabási.

Please provide your email address to receive an email when new articles are posted on . Medicare will begin offering coverage for PrismRA, a molecular diagnostic test that predicts treatment response ...

Augurex Life Sciences Corp., a leader in autoimmune-based diagnostics, today announced an agreement with MitogenDx, a Canadian specialty laboratory focused on autoimmune and rheumatology diagnostic ...